Gentler combo therapy tested to fight leukemia in older patients
NCT ID NCT03480438
Summary
This study tested a new treatment plan for older adults (55-75) newly diagnosed with a fast-growing blood cancer called B-cell acute lymphoblastic leukemia (ALL). The goal was to see if using a lower dose of standard chemotherapy, followed by an immunotherapy drug called blinatumomab, could effectively control the disease while being easier on the body. Researchers measured how well the cancer responded and monitored patients' survival and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-PRECURSOR ALL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité - Campus Benjamin Franklin
Berlin, Germany
-
Evangelisches Krankenhaus Essen-Werden
Essen, Germany
-
Evangelisches Krankenhaus Hamm
Hamm, Germany
-
Gemeinschaftsklinikum Mittelrhein
Koblenz, Germany
-
Helios Klinikum Wuppertal
Wuppertal, Germany
-
Klinikum Bremen Mitte
Bremen, Germany
-
Klinikum Großhadern
München, Germany
-
Klinikum Oldenburg
Oldenburg, Germany
-
Klinikum rechts der Isar der TU München
München, Germany
-
Städtisches Klinikum Braunschweig
Braunschweig, Germany
-
Städtisches Klinikum Karlsruhe
Karlsruhe, Germany
-
Uniklinik Hamburg Eppendorf
Hamburg, Germany
-
Uniklinik RWTH Aachen
Aachen, Germany
-
Uniklinik Würzburg
Würzburg, Germany
-
University Hospital of Frankfurt (Main)
Frankfurt am Main, Hesse, 60590, Germany
-
Universitätsklinik Tübingen
Tübingen, Germany
-
Universitätsklinikum Halle
Halle, Germany
-
Universitätsklinikum Leipzig
Leipzig, Germany
-
Universitätsklinikum Schleswig-Holstein
Kiel, Germany
-
Universitätsklinikum Ulm
Ulm, Germany
-
Vivantes Klinikum Neukölln
Berlin, Germany
Conditions
Explore the condition pages connected to this study.